Legal & General Group
VOR icon

Legal & General Group’s Vor Biopharma VOR Stock Holding History

Legal & General Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
+8,011
New +$121K ﹤0.01% 2600
2024
Q2 		– Sell
-181
Closed -$8.6K – 3514
2024
Q1 		$8.6K Hold
181
– – ﹤0.01% 3232
2023
Q4 		$8.14K Hold
181
– – ﹤0.01% 3264
2023
Q3 		$7.69K Hold
181
– – ﹤0.01% 3316
2023
Q2 		$11.2K Buy
+181
New +$16.5K ﹤0.01% 3298
2022
Q2 		– Sell
-78
Closed -$9K – 3666
2022
Q1 		$9K Hold
78
– – ﹤0.01% 3433
2021
Q4 		$18K Hold
78
– – ﹤0.01% 3312
2021
Q3 		$24K Buy
78
+29
+59% +$8.62K ﹤0.01% 3219
2021
Q2 		$18K Sell
49
-10
-17% -$4.93K ﹤0.01% 3335
2021
Q1 		$51K Buy
+59
New +$49.9K ﹤0.01% 2809

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Legal & General Group's VOR Position: Q2 2026 in Review

Legal & General Group opened a new position in Vor Biopharma (VOR) in Q2 2026: 8,011 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #2600 among its holdings. This is a return to the name: Legal & General Group previously reported a position in VOR as recently as Q1 2024.

Legal & General Group first reported a position in VOR in Q1 2021 and has held it in 10 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Legal & General Group held 8,011 shares of Vor Biopharma worth $147K as of Q2 2026.
  • Vor Biopharma was a new Legal & General Group position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2600 holding.
  • Legal & General Group first reported a position in Vor Biopharma in Q1 2021 and has held it in 10 quarters since.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.